Cao, J., Chen, G., Qiu, L., Zhang, L., Jiang, M., Cheng, Y., . . . Su, W. Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: A multicentre, single-arm, phase 2 studyResearch in context. Elsevier.
Chicago Style (17th ed.) CitationCao, Junning, et al. Efficacy and Safety of Tazemetostat, an EZH2 Inhibitor, in Chinese Patients with Relapsed/refractory Follicular Lymphoma: A Multicentre, Single-arm, Phase 2 StudyResearch in Context. Elsevier.
MLA (9th ed.) CitationCao, Junning, et al. Efficacy and Safety of Tazemetostat, an EZH2 Inhibitor, in Chinese Patients with Relapsed/refractory Follicular Lymphoma: A Multicentre, Single-arm, Phase 2 StudyResearch in Context. Elsevier.
Warning: These citations may not always be 100% accurate.